Lanthanum
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06792 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 15 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | dyspepsia | KG + DL |
| 2 | infectious otitis media | KG + DL |
| 3 | otosalpingitis | KG + DL |
| 4 | middle ear cholesterol granuloma | KG + DL |
| 5 | allergic otitis media | KG + DL |
| 6 | chronic otitis media | KG + DL |
| 7 | middle ear disease | KG + DL |
| 8 | non-suppurative otitis media | KG + DL |
| 9 | suppurative otitis media | KG + DL |
| 10 | pharyngitis | KG + DL |
| 11 | acute laryngopharyngitis | KG + DL |
| 12 | endocardial fibroelastosis | KG + DL |
| 13 | bronchitis | KG + DL |
| 14 | nasal cavity disease | KG + DL |
| 15 | endocarditis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.